{"id":"NCT03329911","sponsor":"Bio-Thera Solutions","briefTitle":"A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer","officialTitle":"A Multicenter, Randomized, Double Blind, Phase III Study of BAT1706 Versus EU Avastin® Plus Chemotherapy in Patients With Advanced Non Squamous Non Small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-20","primaryCompletion":"2019-11-05","completion":"2021-05-27","firstPosted":"2017-11-06","resultsPosted":"2021-09-13","lastUpdate":"2021-09-14"},"enrollment":651,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Non-squamous Non-small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"EU Avastin®","otherNames":[]},{"type":"DRUG","name":"BAT1706","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":[]},{"type":"DRUG","name":"carboplatin","otherNames":[]}],"arms":[{"label":"EU Avastin®","type":"ACTIVE_COMPARATOR"},{"label":"BAT1706","type":"EXPERIMENTAL"}],"summary":"This is a Phase III, randomized, double blind, multicenter, active comparator, parallel two arm study to compare the efficacy, and to evaluate the safety, and immunogenicity of BAT1706 to EU Avastin® in patients with previously untreated advanced non-squamous non-small cell lung cancer (nsNSCLC) to demonstrate clinical equivalence of BAT1706 and EU Avastin®.","primaryOutcome":{"measure":"Overall Response Rate","timeFrame":"Week 18","effectByArm":[{"arm":"EU Avastin®","deltaMin":156,"sd":null},{"arm":"BAT1706","deltaMin":145,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["China","Mexico","South Africa","Turkey (Türkiye)","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":119,"n":324},"commonTop":["Musculoskeletal and connective tissue disorders","Renal and urinary disorders","Neoplasms benign, malignant and unspecified (inclcysts and polyps)","Hepatobiliarydisorders"]}}